4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-125547
Interim CEO & General Counsel gave up 4,426 shares (to pay taxes)
- Interim CEO & General Counsel acquired 10,417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2024-12-02 | Option exercise | +10,417 | 214,662 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2024-12-02 | Shares withheld for taxes | −4,426 | $9.07 | $40,144 | 210,236 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2024-12-02 | Option exercise · Restricted Stock Units | −10,417 | 52,087 | D: show line 3 in the form |
Loading xslF345X05/tm2430163-3_4seq1.xml…